DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, MJ | ko |
dc.contributor.author | Jung, KH | ko |
dc.contributor.author | Kim, D | ko |
dc.contributor.author | Lee, H | ko |
dc.contributor.author | Zheng, HM | ko |
dc.contributor.author | Park, BH | ko |
dc.contributor.author | Hong, SW | ko |
dc.contributor.author | Kim, MH | ko |
dc.contributor.author | Hong, Sungwoo | ko |
dc.contributor.author | Hong, SS | ko |
dc.date.accessioned | 2013-03-09T09:04:54Z | - |
dc.date.available | 2013-03-09T09:04:54Z | - |
dc.date.created | 2012-02-06 | - |
dc.date.created | 2012-02-06 | - |
dc.date.issued | 2011-07 | - |
dc.identifier.citation | CANCER LETTERS, v.306, no.2, pp.190 - 196 | - |
dc.identifier.issn | 0304-3835 | - |
dc.identifier.uri | http://hdl.handle.net/10203/95946 | - |
dc.description.abstract | Hepatocellular carcinoma (HCC) is one of the most common malignancies, yet there have been no significant advances in effective therapeutics. In this study. HS-113 was synthesized as a novel compound. N-(5-(2-bromobenzyl) thiazole-2-yl) benzofuran-2-carboxamide and its cytotoxic activity and anti-cancer effect were examined in human HCC cells. HS-113 strongly suppressed growth of HCC cells in a dose-dependent manner, induced apoptosis by increasing the proportion of sub-G1 apoptotic cells, and caused cell cycle arrest at G0/G1 phase. Also. HS-113 increased the expression of p27 and decreased that of cyclin D1 associated with cell cycle arrest. Apoptosis by HS-113 was confirmed by DAPI and TUNEL staining, and the increases of the cleaved PARP and caspase-3 were observed. Furthermore, HS-113 decreased protein expression of HIF-1 alpha and secretion of VEGF, and inhibited the tube formation of HUVECs. These results showed that HS-113 not only inhibited cell growth and angiogenesis, but also induced apoptosis of human HCC cells. We suggest that HS-113 may be a potential candidate for caner therapy against HCC. (C) 2011 Elsevier Ireland Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | ELSEVIER IRELAND LTD | - |
dc.subject | CANCER CHEMOPREVENTION | - |
dc.subject | VEGF EXPRESSION | - |
dc.subject | BREAST-CANCER | - |
dc.subject | DERIVATIVES | - |
dc.subject | PROTEIN | - |
dc.title | Anti-cancer effects of a novel compound HS-113 on cell growth, apoptosis, and angiogenesis in human hepatocellular carcinoma cells | - |
dc.type | Article | - |
dc.identifier.wosid | 000291188000008 | - |
dc.identifier.scopusid | 2-s2.0-79955479914 | - |
dc.type.rims | ART | - |
dc.citation.volume | 306 | - |
dc.citation.issue | 2 | - |
dc.citation.beginningpage | 190 | - |
dc.citation.endingpage | 196 | - |
dc.citation.publicationname | CANCER LETTERS | - |
dc.contributor.localauthor | Hong, Sungwoo | - |
dc.contributor.nonIdAuthor | Choi, MJ | - |
dc.contributor.nonIdAuthor | Jung, KH | - |
dc.contributor.nonIdAuthor | Kim, D | - |
dc.contributor.nonIdAuthor | Lee, H | - |
dc.contributor.nonIdAuthor | Zheng, HM | - |
dc.contributor.nonIdAuthor | Park, BH | - |
dc.contributor.nonIdAuthor | Hong, SW | - |
dc.contributor.nonIdAuthor | Kim, MH | - |
dc.contributor.nonIdAuthor | Hong, SS | - |
dc.type.journalArticle | Article | - |
dc.subject.keywordAuthor | HS-113 | - |
dc.subject.keywordAuthor | Apoptosis | - |
dc.subject.keywordAuthor | Angiogenesis | - |
dc.subject.keywordAuthor | HCC | - |
dc.subject.keywordPlus | CANCER CHEMOPREVENTION | - |
dc.subject.keywordPlus | VEGF EXPRESSION | - |
dc.subject.keywordPlus | BREAST-CANCER | - |
dc.subject.keywordPlus | DERIVATIVES | - |
dc.subject.keywordPlus | PROTEIN | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.